Drugs / VEGF-A165 plasmid
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00135850 | Mar 2003 → Feb 2005 | myocardial ischemia | Rigshospitalet, Denmark | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VEGF-A165 plasmid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00135850 ↗ |
| Modality | Other / unclassified | “VEGF delivered as plasmid DNA” NCT00135850 ↗ |
| Route | Other | “VEGF delivered as plasmid DNA percutaneously by a catheter-based, intramyocardial approach” NCT00135850 ↗ |